PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: bankruptcy

Intravenous Iron Replacement Therapy

Page 1 of 5 Coverage Policy Number: IP0222 Drug and Biologic Coverage Policy Effective Date .. 1/1/2022 Next Review .. 1/1/2023 Coverage Policy Number .. IP0222 Intravenous iron Replacement Therapy Table of Contents Overview .. 1 Medical Necessity Criteria .. 2 Reauthorization Criteria .. 2 Authorization Duration .. 2 Conditions Not 2 Coding / Billing Information .. 2 Background .. 3 References .. 5 Related Coverage Resources INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations.

Ferric carboxymaltose is a colloidal iron (III) hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron. ... infusion within a 28-day period: two 300 mg infusions over 1.5 hours 14 days apart, then one 400 mg infusion over 2.5 hours 14

Fullscreen Download

Tags:

  Iron, Infusion, Ferric, Ferric carboxymaltose, Carboxymaltose

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Intravenous Iron Replacement Therapy

Documents from same domain

Molecular Diagnostic Testing for Hematology and Oncology ...

static.cigna.com

General Criteria for Somatic Mutation Genetic Testing ... initiate a related therapy and the therapy has been validated by the National Comprehensive Cancer Network™ (NCCN Guidelines™) as a category 1, 2A, or 2B recommendation for the ... Detection of circulating whole tumor cells for any other indication is considered experimental,

  Detection, Validated, Mutation

Bariatric Surgery and Procedures - Cigna

static.cigna.com

This Coverage Policy addresses bariatric surgery and procedures for the treatment of morbid obesity. Coverage Policy . Coverage for bariatric surgery or revision of a bariatric surgery procedure varies across plans and may be governed by state mandates. Refer to the customer’s benefit plan document for coverage details.

  Surgery, Bariatric, Bariatric surgery

Anesthesia Services for Interventional Pain Management ...

static.cigna.com

Monitored anesthesia care (MAC) is a service rendered by an anesthesia practitioner (i.e., anesthesiologist, certified registered nurse anesthetist CRNA]) who is not involved in the diagnostic or procedural service being performed. The ASA defines MAC as

  Services, Management, Pain, Anesthesia, Interventional, Monitored, Monitored anesthesia, Anesthesia services for interventional pain management

REVENUE CODE LIST-CPT-HCPCS - Cigna

static.cigna.com

REVENUE CODE LIST-CPT-HCPCS For Providers Effective March 15, 2020 . All Cigna products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, includingCigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Cigna Behavioral Health, Inc., and HMO or service

  Code, Revenue, Revenue codes

Minimally Invasive Spine Surgery Procedures and Trigger ...

static.cigna.com

Trigger Point: Trigger point injection therapy involves the injection of anesthetic or corticosteroids into distinct, focal hyper-irritable spots (i.e., trigger points) located in a tight band of skeletal muscle. Myofascial pain syndrome is a chronic form of muscle pain centered near trigger points.

  Triggers

Diabetes Equipment and Supplies

static.cigna.com

• hypoglycemic wristband alarm (e.g., Diabetes Sentry™) External Insulin Pumps . ANY of the following external insulin pumps * is considered medically necessary for the management of type 1 and type 2 diabetes mellitus: • an external insulin pump* (HCPCS code E0784) including a combined or integrated continuous

  Hypoglycemic

Welcome to Cigna Behavioral Health

static.cigna.com

The practitioner has thirty (30) days from the receipt of the suspension or termination letter to make a written request for reconsideration. Cigna Behavioral Health's Credentialing Committee Appeal Panel will review the appeal at its next monthly meeting and issue a written notification of the outcome to the practitioner.

  Practitioner

Speech Therapy - Cigna

static.cigna.com

speech-language pathologist for a significant voice disorder associated with the laryngeal structures that are associated with anatomic abnormality, neurological condition, injury (e.g., vocal nodules or polyps, vocal cord paresis or paralysis, paradoxical vocal …

  Paralysis, Laryngeal

Nucleic Acid Pathogen Testing - Cigna

static.cigna.com

o human papillomavirus (HPV) cervical cancer screening • Symptomatic individuals when the associated signs and symptoms or diagnoses, are listed in the ... Chlamydial infection is the most frequently reported infectious disease in the United States (IDSA, 2018; CDC,

  Pathogens, Testing, Human, Acid, Infections, Cervical, Nucleic, Papillomavirus, Human papillomavirus, Nucleic acid pathogen testing

Transcranial Magnetic Stimulation

static.cigna.com

Transcranial Magnetic Stimulation (TMS) for Depression . Transcranial magnetic stimulation (TMS) is a non-invasive neurostimulation technique that modulates cortical excitability. In repetitive TMS (rTMS), trains of several pulses are delivered through repeated stimulation over the same area with frequencies ranging from 1 to 20 Hz.

  Stimulation

Related documents

Overview - What is an iron infusion? - Melbourne Haematology

www.melbournehaematology.com.au

Ferric carboxymaltose (FCM) also known as FERINJECT® is an intravenous (IV) iron preparation, a medicine that is used in the treatment of iron deficiency conditions such as iron-deficiency anaemia (IDA). It contains iron in the form of ferric carboxymaltose, an iron carbohydrate compound. Iron is an essential element required for the oxygen ...

  Iron, Infusion, Ferric, Ferric carboxymaltose, Carboxymaltose, Iron infusion

Hematology for Family Practice When to treat and when to refer

cdn.ymaws.com

Ferric carboxymaltose (Injectafer): is a colloidal iron hydroxide complex with a tighter binding of elemental iron. It’s a 15 minute infusion and doesn’t require premeds and is given in NSS 750 mg in 2 doses, one week apart.

  Iron, Infusion, Ferric, Ferric carboxymaltose, Carboxymaltose

NEW ZEALAND DATA SHEET 1 PRODUCT NAME 2 ... - Medsafe

www.medsafe.govt.nz

less than 2 mg iron/mL (not including the volume of the ferric carboxymaltose solution). Table 3: Dilution plan of FERINJECT for intravenous infusion FERINJECT Iron Maximum amount of sterile 0.9% m/V sodium chloride solution Minimum administration time 2 to 4 mL 100 to 200 mg 50 mL 3 minutes >4 to 10 mL >200 to 500 mg 100 mL 6 minutes

  Iron, Infusion, Ferric, Ferric carboxymaltose, Carboxymaltose

Package leaflet: Information for the patient Ferinject 50 ...

www.medicines.org.uk

Ferinject 50 mg iron/mL solution for injection/infusion . Ferric carboxymaltose . Read all of this leaflet carefully before you are given this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If …

  Information, Patients, Iron, Leaflet, Packages, Infusion, Ferric, Package leaflet, Ferinject, Ferric carboxymaltose, Carboxymaltose, Information for the patient ferinject

AUSTRALIAN PRODUCT INFORMATIONFERINJECT (FERRIC ...

www.tga.gov.au

Ferric carboxymaltose 2 QUALITATIVE AND QUANTITATIVE COMPOSITION . Each 2 mL vial contains 100 mg of iron as ferric carboxymaltose. Each 10 mL vial contains 500 mg of iron as ferric carboxymaltose. Each 20 mL vial contains 1000 mg of iron as ferric carboxymaltose. For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS.

  Iron, Ferric, Ferric carboxymaltose, Carboxymaltose

Ferric (Iron) Carboxymaltose by infusion - Ministry of Health

seslhd.health.nsw.gov.au

Dilution and administration plan for Ferinject® (ferric carboxymaltose) for intravenous infusion Iron dose (ferric carboxymaltose) Maximum volume of sterile sodium chloride 0.9% solution Minimum administration time 100–200mg 50 mL 3 minutes 500mg 100 mL 6 minutes 501-1000mg 250 mL 30 minutes

  Iron, Infusion, Ferric, Ferric carboxymaltose, Carboxymaltose, Iron infusion, Carboxymaltose by infusion

Feraheme® (ferumoxytol) and Injectafer® (ferric ...

www.aetna.com

(ferric carboxymaltose) Medication Precertification Request . Aetna Precertification Notification . Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review) Please indicate: Start of treatment: Start date

  Aetna, Medication, Request, Precertification, Ferric, Medication precertification request, Ferric carboxymaltose, Carboxymaltose

Related search queries

Iron infusion, Ferric carboxymaltose, Iron, Infusion, Package leaflet: Information for the patient Ferinject, Ferric, Ferric (Iron) Carboxymaltose by infusion, Infusion Iron, Ferric carboxymaltose) Medication Precertification Request, Aetna